Kallikrein-related peptidase 7 is a potential target for the treatment of pancreatic cancer

Jian Ping Du(China Three Gorges University), Xiao Tan(Tongji University), Sen Liu(Shenyang Pharmaceutical University), Lin Li(China Pharmaceutical University), Wei Liu(Second People’s Hospital of Yibin), Ding Zhang(Shaanxi Provincial People's Hospital), Jun Zheng(China Three Gorges University), Wei Hong Zheng(China Three Gorges University), Fangyu Wang(Affiliated Hospital of Jining Medical University), Ru Yao(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiao Song Li(China Three Gorges University)
Oncotarget
January 10, 2018
10.18632/oncotarget.24132
Cited by 28

Related Papers

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization
|Journal of Neuroinflammation|2020|609
Discovery of (10 <i>R</i> )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- <i>2H</i> -8,4-(metheno)pyrazolo[4,3- <i>h</i> ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations
|Journal of Medicinal Chemistry|2014|587
Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11
|Cancer Research|2021|280
Parthenolide promotes the repair of spinal cord injury by modulating M1/M2 polarization via the NF-κB and STAT 1/3 signaling pathway
|Cell Death Discovery|2020|179